Cynthia Lebsack - Concepedia

Author

Cynthia Lebsack

Stanford University

Also Known As

C Lebsack, C S Lebsack, C. Lebsack, Cynthia Lebsack, Cynthia S. Lebsack

Publications

510

Citations

H-Index

Concepts

All Affiliations

Stanford University Sequoia Hospital Stanford Medicine

About

Cynthia Lebsack is an author at Stanford University specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	456
2	Pharmacology	5	5	366
3	Public Health	2	2	62
4	Emergency Medicine	1	1	15
5	Pathology	1	1	28

Cynthia Lebsack

Publications

500

Citations

H-Index

Page 1

	Year	Citations
Clinical pharmacology of propafenone. Stuart J. Connolly, Robert E. Kates, Cynthia Lebsack, Circulation Heart FailurePropafenone DoseCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1983	183
Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia Stuart J. Connolly, Robert E. Kates, Cynthia Lebsack, The American Journal of Cardiology Cardiogenic ShockCardiovascular DiseaseMedicinePhysiologyCardiovascular Pharmacology	1983	85
Clinical experience with sotalol in patients with drug-refractory ventricular Arrhythmias Michael A. Ruder, Tamara Ellis, Cynthia Lebsack, Journal of the American College of Cardiology Drug-refractory Ventricular ArrhythmiasHeart FailureCardiovascular DiseaseMedicineCardiovascular Pharmacology	1989	62
Very long term outcomes of atrial fibrillation ablation Roger A. Winkle, R. Hardwin Mead, Gregory Engel, Heart Rhythm ThrombosisElectrophysiological EvaluationCardiovascular DiseaseCoagulopathyAtrial Fibrillation Ablation	2023	47
Propafenone disposition kinetics in cardiac arrhythmia Stuart J. Connolly, Cynthia Lebsack, Roger A. Winkle, Clinical Pharmacology & Therapeutics	1984	44
“Purple toes” syndrome Cynthia Lebsack, Robert T. Weibert Postgraduate Medicine Thumb HypoplasiaPurple ToesGeneralized Skin EruptionPathologyWarfarin Sodium	1982	28
Clinical pharmacology of intravenous enoximone: Pharmacodynamics and pharmacokinetics in patients with heart failure Nellis A. Smith, Robert E. Kates, Cynthia Lebsack, American Heart Journal Heart FailureCardiovascular DiseaseMedicineCardiovascular PharmacologyIntravenous Enoximone	1991	26
Ethmozine: Electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias Paul Dorian, Debra S. Echt, R. Hardwin Mead, American Heart Journal Electrophysiological EvaluationHeart FailureCardiac AnaesthesiaCardiovascular DiseaseArrhythmia	1986	15
Propafenone: a new antiarrhythmic agent. Moses S. S. Chow, Cynthia Lebsack, D. E. Hilleman PubMed Molecular PharmacologyHeart FailureCardiovascular DiseaseMedicinePhysiology	1988	10

Page 1